In pancreatic ductal adenocarcinoma (PDA) cells in vitro, loss of ANXA6 in CAF altered the development of ANXA6, LRP1, and TSP1 complexes, suppressing PDA and metastasis (31). This evidence concerns the gene ANXA6 and Patent ductus arteriosus.